Intermediate process effectiveness and cumulative systems effectiveness analyses for IPTp were performed on women receiving IPTp in an eligible month of gestation (4 to 9 months) and excluded women who did not receive IPTp and who were taking cotrimoxazole as documented on ANC cards as per national policy.
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}